Recorded: May 26th | 1:00 p.m. ET

The SEC’s new Rule 2a-5 has important ramifications for anyone in the business of pricing hard-to-value instruments. It requires valuation practitioners to demonstrate good faith in implementing and following a defensible and transparent processes. But what does this mean as a practical matter?

On Wednesday, May 26th experts David Baum and Martin Dozier of Alston & Bird and Bill Moretti and Joe Sturtevant of RiskSpan explained and responded to your questions about:

  • What the new requirements are
  • Who is impacted and when
  • Implementation best practices
  • Potential issues with Rule 17a-7, and
  • Modeling considerations, including assumptions, back-testing, calibration, and data management.

Featured Speakers

William Moretti

Senior Managing Director, RiskSpan

David Baum

Partner, Investment Management, Trading and Markets Group, Alston & Bird LLP

Martin Dozier

Partner, Alston & Bird LLP

Joseph Sturtevant

Head of Valuation Services, RiskSpan